Rossella De Cecio Selected Research

Rossella De Cecio Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 01/2009
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 02/2017
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 07/2020
2	Disease Progression 01/2023 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 03/2022
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 11/2016
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Adenocarcinoma 03/2022
1	Adenocarcinoma of Lung 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Hemorrhage 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 07/2019
1	Carcinogenesis 05/2019
1	Breast Neoplasms (Breast Cancer) 02/2017
1	Triple Negative Breast Neoplasms 02/2017
1	Hemangiosarcoma (Angiosarcoma) 01/2017

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2017
4	B7-H1 AntigenIBA 01/2020 - 05/2016
3	AntibodiesIBA 02/2017 - 05/2016
2	domatinostatIBA 04/2022 - 03/2022
2	Cell-Free Nucleic AcidsIBA 01/2022 - 12/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2020
2	Bevacizumab (Avastin)FDA Link 10/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2017
2	Cetuximab (Erbitux)FDA Link 01/2020 - 11/2016
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 11/2016
1	avelumabIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	TrabectedinIBA 01/2022
1	PM 01183IBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 02/2021
1	HMGA ProteinsIBA 01/2021
1	PlatinumIBA 09/2020
1	NivolumabIBA 09/2020
1	pembrolizumabIBA 09/2020
1	Messenger RNA (mRNA)IBA 07/2020
1	atezolizumabIBA 07/2020
1	Monoclonal AntibodiesIBA 07/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	RamucirumabIBA 01/2020
1	ParaffinIBA 01/2020
1	Generic DrugsIBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Integrin alphaVIBA 07/2019
1	IntegrinsIBA 07/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Estrogen Receptor alphaIBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	Fluorouracil (Carac)FDA LinkGeneric 11/2016

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2023 - 11/2016
3	Immunotherapy 01/2023 - 01/2017
1	Intravenous Infusions 01/2020
1	Biological Therapy 01/2018
1	Oral Surgical Procedures 07/2016
1	Radiotherapy 01/2009